Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Substudy of the the CANTOS Trial (Interleukin-1 Blockade With Canakinumab to Improve Exercise Capacity in Patients With Chronic Systolic Heart Failure and Elevated Hs-CRP; CACZ885M2301)

NCT01900600 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.

NCT NCT01900600
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01900600 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Substudy of the the CANTOS Trial (Interleukin-1 Blockade With Canakinumab to Improve Exercise Capacity in Patients With Chronic Systolic Heart Failure and Elevated Hs-CRP; CACZ885M2301)
Lead sponsor
Virginia Commonwealth University
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2013
Completion date
January 8, 2015
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

evidence of systemic inflammation (c reactive protein plasma >2 mg/l), prior acute myocardial infarction, reduced left ventricle ejection fraction (<50%), symptoms of heart failure (nyha class ii-iii)